Articles in section Licensing
| << Joint Venture | 512 articles | Mergers & Acquisitions >> |
| << Previous | Pages 1 ..4 5 6 7 8 9 .. 52 | Next >> |
-
Novartis Licenses Mesoblast’s Stem Cell Therapy Remestemcel-L
-
Dyno Therapeutics Signs US$1.8 B Gene Therapy Pact with Roche
-
Sanofi Delves Further into Protein Degrader Therapies with US$2.33 B Kymera Deal
-
Roche and Blueprint Medicines Partner Again in US$1.7 B Pralsetinib Pact
-
AstraZeneca Signs US$6 B ADC Collaboration with Daiichi Sankyo for DS-1062
-
CSL Behring Licenses Phase III Haemophilia B Gene Therapy Candidate from uniQure
-
Neurocrine Biosciences Licenses Seven Psychiatric Programmes from Takeda in US$2 B Deal
-
Five Prime Signs US$530 M Licensing Deal with Seattle Genetics
-
Gilead Collaborates with Kyverna Therapeutics on T-cell Therapies
-
Pfizer Licenses eFFECTOR's eIF4E Inhibitors to Bolster Oncology Pipeline
RSS